Instead, calretinin had a positive reaction only in two cases, with moderate or weak/moderate immunostaining in 60% and, respectively, 55% of the tumor cells, and the specific neuronal enolase was weakly positive in two cases, with a focal reaction of up to 30% of tumor cells. The gene discussed is CALB2; the disease is neoplasm.